HER-1 vaccine - Center of Molecular Immunology

Drug Profile

HER-1 vaccine - Center of Molecular Immunology

Alternative Names: HER-1-ECD-VSSP; HER1-ECD; HER1-VSSP vaccine

Latest Information Update: 06 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Center of Molecular Immunology
  • Class Cancer vaccines
  • Mechanism of Action Epidermal growth factor receptor antagonists; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Cancer
  • Phase I Prostate cancer

Most Recent Events

  • 16 Dec 2016 Phase-I development is ongoing in Prostate cancer in Cuba
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top